PIK3CG and non-Hodgkin lymphoma: Recent evidence indicates frequent mutation in histone modifying proteins and dysregulation of PI3K pathway in non-Hodgkin lymphoma (NHL), particularly in diffuse large B-cell lymphoma (DLBCL).